Skip to content
  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
PHP Toggle Menu

Category: Myvac

myvac™ Viral based vaccine for personalized neoantigen-directed cancer therapy

Christian Ottensmeier, et al. SITC 2018, November 2018 – Abstract available on the SITC website Download the poster here Poster Presentation Collaboration between Transgene – University of Southampton, United Kingdom – La Jolla Institute for allergy and immunology, USA – University of Copenhagen, Denmark

Published 7 November 2018
Categorized as 2018, Myvac, Publication

Transgene Highlights its Broad Viral Vector Expertise at the Society for Immunotherapy of Cancer (SITC) 2018 Conference

20181107 SITC Poster EN

Published 7 November 2018
Categorized as 2018, Invir.IO, Myvac, Press release

NEC and Transgene announce a collaboration in the field of individualized cancer immunotherapy, leveraging NEC’s AI and Transgene’s myvac™ platform

Press Release NEC- Transgene EN

Published 30 October 2018
Categorized as 2018, Myvac, Press release

Transgene to Present its Viral Vector Expertise at the Society for Immunotherapy of Cancer Conference

20181001 SITC Poster VEN

Published 2 October 2018
Categorized as 2018, Invir.IO, Myvac, Press release

Transgene unveils myvac™, an individualized immunotherapy against solid tumors

20180924 MyVac EN

Published 24 September 2018
Categorized as 2018, Myvac, Press release

Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer

K. Bendjama, E. Quéméneur Human Vaccines and Immunotherapeutics, August 2017 – Read the article Publication

Published 26 August 2017
Categorized as 2017, Myvac, Publication, publication key en, TG4050

Posts pagination

Newer posts Page 1 … Page 7
Get to know us

About us

myvac

Pipeline

Investors

Partnering

Company

Career

ESG

Suppliers

Contacts

Legal documents

Legal notices

Privacy Policy

Ethics and compliance

Cookie policy

  • About us
    • About us
    • Executive commitee
    • Board of Directors
    • Scientific advisors
    • Corporate governance
    • ESG
  • myvac
    • myvac – individualized therapeutic vaccines
  • Pipeline
    • Pipeline
    • TG4050
    • TG4070
    • BT-001
    • TG6050
    • Publications and Presentations
    • Clinical trials FAQ
  • Investors
    • Investor Presentation & Contacts
    • Press releases & events
    • Financial Information
    • Stock Information
    • Annual General Meeting
  • Career
  • English
  • French
Menu